Back to Selection     Print       Date : 30 Sep 2026
Fund Summary
Aditya Birla SL Pharma & Healthcare Fund (G)
[Equity: Sectoral]  
 
Fund Details
Fund Type Growth Launch Date 10-Jul-19
Corpus(Cr.) 1078.00 Latest NAV 34.97 As on 29-10-2026
Equity(%) 97.94 52 Week High 37
Debt(%) 2.06 52 Week Low 29.27
Others(%) 0.00 Exit Load 1% for redemption within 30 days
Minimum Investment - Availability
Entry Load Nil Expense Ratio(%) 0.00
Scheme Benchmark BSE Healthcare TRI Broader Benchmark NSE - Nifty 50 TRI
Fund Manager Dhaval Shah
 
Riskometer
Investors understand that their principal will be at Very High risk
 
Scheme Objective
The scheme seeks to provides long term capital appreciation by investing in equity/equity related instruments of the companies in the Pharmaceuticals, Healthcare and Allied sectors in India.

Portfolio Classification
 
Asset Mix
 
Concentration Analysis
Top 5 Holdings 35.23%
Top 10 Holdings 54.46%
Top 25 Holdings 87.04%
 
Sector Analysis
Sector/Ratings Net Asset(%)
Pharma & Biotech 74.91
Healthcare 21.61
Cash 2.06
Miscellaneous 0.73
Chemicals 0.69
 
 
 
 
 
Portfolio Metrics
PB Ratio 5.64
PE Ratio 40.49
 
Top 25 Holdings
Holdings Net Asset(%)
Torrent Pharmaceuticals Ltd. 9.28
Sun Pharmaceutical Industries Ltd. 8.61
Apollo Hospitals Enterprises Ltd. 6.44
Cipla Ltd. 6.38
Aurobindo Pharma Ltd. 4.52
Sai Life Sciences Limited 4.49
Ajanta Pharma Ltd. 4.35
Mankind Pharma Limited 3.62
Dr. Lal Pathlabs Limited 3.51
Abbott India Ltd. 3.26
Emcure Pharmaceuticals Limited 3.21
Lupin Ltd 2.94
TREPS 2.92
Ipca Laboratories Ltd. 2.71
Gland Pharma Limited 2.70
Fortis Healthcare Ltd 2.42
Corona Remedies Limited 2.27
Divis Laboratories Ltd. 2.24
PROCTER & GAMBLE HEALTH LIMITED 1.82
Thyrocare Technologies Limited 1.76
Alkem Laboratories Limited 1.68
EQ- JUPITER LIFE LINE HOSPITALS LTD 1.55
Metropolis Healthcare Limited 1.48
Biocon Ltd. 1.45
Shilpa Medicare Ltd. 1.43

Performance Analysis
 
Short Terms Returns
1 Month 3 Month 6 Month 1 Year
-3.66% -3.58% 10.49% 11.51%
 
Broader Market Benchmark [NSE - Nifty 50 TRI]
1.01% -5.23% -4.33% -11.05%
 
Scheme Benchmark [NSE - Nifty Healthcare TRI]
-2.23% -2.98% 8.71% 8.99%
 
Long term Returns
2 Year 3 Year 5 Year 10 Year
6.04% 19.29% 13.04% 0.00%
 
 
-2.07% 7.60% 6.59% 11.58%
 
 
6.75% 21.05% 14.18% 10.60%
 
Cumulative Performance of Last 5 Years
 
Calendar Year Returns

Risk Analysis
 
Absolute Metrics (Single Computation - last 3 years)
Scheme Name Standard Deviation Sharpe Ratio Downside Deviation Downside Probability Sortino Ratio
Aditya Birla SL Pharma & Healthcare Fund (G) 15.55% 1.0663 10.1037% 42.2973 0.1525
 
Benchmark Relative Metrics (Single Computation - last 3 years)
Scheme Name Alpha Beta Treynor Ratio Tracking Error Information Ratio
Aditya Birla SL Pharma & Healthcare Fund (G) 15.7619% 0.0000 -12.3403 18.9566 1.8975
 
Back to Selection